Bio Rad Laboratories Stock

Bio Rad Laboratories EBIT

The EBIT of Bio Rad Laboratories (BIO) as of Jul 25, 2026 is 270.50 M USD. In the previous year, EBIT was 269.00 M USD — a change of 0.56% (higher).

EBIT

270.50 MUSD

YoY

0.56%

Last updated:

In 2026, Bio Rad Laboratories's EBIT was 270.50 M USD, a 0.56% increase from the 269.00 M USD EBIT recorded in the previous year.

The Bio Rad Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2020
443.19 base
Jan 1, 2021
501.89 base
Jan 1, 2022
482.62 base
Jan 1, 2023
337.80 base
Jan 1, 2024
269.00 base
Jan 1, 2025
270.50 base
Jan 1, 2026 (e)
334.19 base
Jan 1, 2027 (e)
367.64 base
YEAREBIT (M USD)
2027 est 367.64
2026 est 334.19
2025 270.50
2024 269.00
2023 337.80
2022 482.62
2021 501.89
2020 443.19
2019 229.66
2018 -108.64
2017 115.97
2016 53.19
2015 166.71
2014 149.98
2013 169.46
2012 264.11
2011 295.16
2010 284.01
2009 230.99
2008 182.94
2007 135.19
2006 146.11
Access this data via the Eulerpool API

Bio Rad Laboratories Revenue

Bio Rad Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
2.55 B USD
443.19 M USD
3.81 B USD
Jan 1, 2021
2.92 B USD
501.89 M USD
4.25 B USD
Jan 1, 2022
2.80 B USD
482.62 M USD
-3.63 B USD
Jan 1, 2023
2.67 B USD
337.80 M USD
-637.32 M USD
Jan 1, 2024
2.57 B USD
269.00 M USD
-1.84 B USD
Jan 1, 2025
2.58 B USD
270.50 M USD
759.90 M USD
Jan 1, 2026 (e)
2.57 B USD
334.19 M USD
253.99 M USD
Jan 1, 2027 (e)
2.63 B USD
367.64 M USD
274.29 M USD

Bio Rad Laboratories Margins

Bio Rad Laboratories stock margins

The Bio Rad Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio Rad Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio Rad Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
56.48 %
17.41 %
149.83 %
Jan 1, 2021
56.05 %
17.17 %
145.57 %
Jan 1, 2022
55.93 %
17.22 %
-129.45 %
Jan 1, 2023
53.42 %
12.65 %
-23.86 %
Jan 1, 2024
53.73 %
10.48 %
-71.86 %
Jan 1, 2025
52.01 %
10.47 %
29.42 %
Jan 1, 2026 (e)
52.01 %
13.02 %
9.89 %
Jan 1, 2027 (e)
52.01 %
13.95 %
10.41 %

Bio Rad Laboratories Stock analysis

What does Bio Rad Laboratories do? Bio-Rad Laboratories Inc. is a leading company in the field of scientific research based in Hercules, California. The company was founded in 1952 by two brothers and has since developed into a multinational company with over 8,000 employees worldwide. Bio-Rad has branches in over 100 countries and its products are used in biotechnology, pharmaceuticals, and the food industry. History Bio-Rad was founded in 1952 by the couple David and Alice Schwartz. They started with the production of blood group serology tests and later expanded their product range to include immunchemicals, electrophoresis equipment, and antibodies. In the 1970s, Bio-Rad developed the first commercial protein A purification system, which is still an important component of protein research today. Business model Bio-Rad's business model is focused on providing high-quality products and services to support customers in their scientific research. The company has various divisions such as life science research, clinical diagnostics, and life science education, which offer products and solutions for scientists, researchers, and diagnosticians. Life science research The life science research division offers a wide range of products and services for biological research. This includes PCR systems, electrophoresis equipment, antibodies, proteins, cell counters, and much more. Bio-Rad's products are used by scientists and researchers around the world to better understand the intricacies of life and the mechanisms of diseases. Clinical diagnostics Bio-Rad's clinical diagnostics division provides a broad spectrum of diagnostic products and solutions for hospitals, laboratories, and medical facilities. The company provides clinical diagnostic instruments, reagents, testing systems, and software to support the diagnostic process. Life science education The life science education division offers innovative and interactive teaching and learning materials for scientific research to teachers, professors, and students. Bio-Rad's products and solutions support the better understanding of the intricacies of life and the mechanisms of diseases in the fields of biology, chemistry, and physics. Products Bio-Rad offers a wide range of products and solutions for research and diagnostics. These include, among others: PCR systems: Bio-Rad offers various PCR systems that help researchers and diagnosticians amplify and analyze DNA. The systems are highly precise and provide reliable results. Proteins and antibodies: Bio-Rad offers a wide selection of proteins and antibodies for research and diagnostics. The products include various types of proteins and antibodies needed for the analysis of protein functions and interactions. Electrophoresis equipment: Bio-Rad provides various electrophoresis equipment that plays an important role in research and diagnostics. The products include gel electrophoresis systems, Western blot systems, and devices for protein analysis. Clinical diagnostics: Bio-Rad offers a wide range of diagnostic products for hospitals, laboratories, and medical facilities. These include immunoassay products, blood group serology tests, and devices for the diagnosis of infectious diseases. In summary, Bio-Rad Laboratories Inc. is a leading company in the field of scientific research. The company offers a wide range of products and solutions for research and diagnostics, supporting scientists, researchers, and diagnosticians around the world in exploring the intricacies of life and better understanding diseases. Bio Rad Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Bio Rad Laboratories's EBIT

Bio Rad Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Bio Rad Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Bio Rad Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Bio Rad Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Bio Rad Laboratories stock

EBIT of Bio Rad Laboratories is 270.50 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Bio Rad Laboratories

All Key Metrics — Bio Rad Laboratories